Dr. Christina Rångemark Åkerman is President of ICHOM and Senior Institute Associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School.
She is a former Director General for the Medical Products Agency (MPA) in Sweden – a national agency employing approximately 750 people and under the aegis of the Swedish Ministry of Health and Social Affairs. She has also been a Member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union.
Before her position with MPA, Dr Rångemark Åkerman served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines.
She has also been working chair of start-up companies and on the Board of Fouriertransform, a Swedish state-owned venture capital Company.